Showing 831-840 of 3425 results for "".
Exploring the Connection Between Gut Health and Hair
https://practicaldermatology.com/issues/supplements/exploring-the-connection-between-gut-health-and-hair/23089/Sponsored by Nutrafol®Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-3/23049/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/20965/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/21300/A.G.E. Interrupter Advanced: Newest Innovative Anti-Aging Cream
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/age-interrupter-advanced-newest-innovative-anti-aging-cream/23930/'Clean Beauty' in Dermatology: A Scoping Review
https://practicaldermatology.com/issues/july-2025/clean-beauty/36492/The emergence of “clean beauty” as a consumer label has become a notable marketing trend, developed in the absence of standardized regulatory definitions, and it has been associated with shifts in consumer behaviors on a global scale.Exploring the Connection Between Gut Health and Hair
https://practicaldermatology.com/topics/general-topics/exploring-the-connection-between-gut-health-and-hair-1/23110/Atopic Dermatitis: A Review of Common Comorbidities
https://practicaldermatology.com/topics/atopic-dermatitis/atopic-dermatitis-a-review-of-common-comorbidities/23352/It is important to acknowledge and identify comorbidities to successfully manage AD and improve patient quality of life.Smoothing Out Our Understanding of Moisturizers
https://practicaldermatology.com/topics/skin-cancer-photoprotection/smoothing-out-our-understanding-of-moisturizers/20688/New science and new approaches for dry skin.The HRQoL Impact of Psoriasis: Perspectives for Value-Based Reimbursement
https://practicaldermatology.com/topics/psoriasis/the-hrqol-impact-of-psoriasis-perspectives-for-value-based-reimbursement/20932/Understanding the psychological/social burden of psoriasis on patients is critical as new therapeutics position themselves for reimbursement in a crowded and increasingly undifferentiated field.